Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indisulam + Irinotecan in Metastatic Colorectal Cancer
NCT00165867Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2005
- Modality
- RNA-Targeting Small Molecules, Molecular Glues
- Countries
- 2
01
Overview
A Phase 2 trial of indisulam in metastatic colorectal cancer (mCRC), sponsored by Eisai Co., Ltd.. Started Apr 2005; status: completed.
02
Drugs
indisulam
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00165867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165867.